医学
结直肠癌
内科学
体质指数
危险系数
癌症
存活率
生存分析
总体生存率
比例危险模型
肿瘤科
子群分析
外科
胃肠病学
荟萃分析
置信区间
作者
Constantinos Simillis,Beth Taylor,Ayesha Ahmad,Nikhil Lal,Thalia Afxentiou,Michael Powar,Elizabeth Smyth,Nicola Fearnhead,James M. Wheeler,Richard J. Davies
标识
DOI:10.1016/j.ejca.2022.05.020
摘要
Background The impact of body mass index (BMI) on long-term survival outcomes after colorectal cancer surgery is debated. Design A systematic literature review and meta-analysis was performed to compare long-term survival outcomes of patients of different BMI categories after colorectal cancer surgery. Results Of the 2588 articles screened, 56 articles met the inclusion criteria, reporting on 72,582 participants. Patients with BMI <18.5 had significantly worse overall survival [hazard ratio (HR) 1.91; P < 0.0001], cancer-specific survival (HR = 1.91; P < 0.0001), disease-free survival (HR = 1.50; P < 0.0001) and recurrence-free survival (HR = 1.13; P = 0.007) compared to patients with a BMI of 18.5–25. There was no significant difference between those with BMI 25–30 and 18.5–25 in overall survival, cancer-specific survival, disease-free survival and recurrence-free survival, except for the subgroup of patients with colon cancer where patients with BMI 25–30 had significantly improved overall survival (HR = 0.90; P = 0.05) and disease-free survival (HR = 0.90; P = 0.04). Patients with BMI >30 had significantly worse disease-free survival (HR = 1.05; P = 0.03) compared to patients with a BMI of 18.5–25, but no significant difference in overall survival, cancer-specific survival and recurrence-free survival. Patients with BMI >35 compared to 18.5–25 had significantly worse overall survival (HR = 1.24; P = 0.02), cancer-specific survival (HR = 1.36; P = 0.01), disease-free survival (HR = 1.15; P = 0.03) and recurrence-free survival for colon (HR = 1.11; P = 0.04) and rectal (HR = 4.10; P = 0.04) cancer. Conclusions Being underweight (BMI < 18.5) or class II/III obese (BMI > 35) at the time of colorectal cancer surgery may result in worse long-term survival outcomes, whereas being overweight (BMI 25–30) may improve survival in a subgroup of patients with colon cancer. Optimising BMI may preoperatively improve long-term survival after surgery for colorectal cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI